国邦医药 (605507.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(国邦医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
主要指标:
 营业收入(元) 4,418,147,150.192,892,356,514.661,338,703,044.525,349,447,853.454,053,476,803.522,809,720,242.621,410,162,706.26
 营业利润(元) 673,947,665.53472,459,269.30236,105,375.84702,263,470.06563,975,837.46417,515,967.87230,550,561.32
 利润总额(元) 664,632,411.33464,089,147.75234,023,535.39697,648,581.22559,550,561.80412,906,121.21228,633,029.61
 净利润(元) 578,638,198.06404,368,991.62198,578,686.05609,978,692.54487,655,739.51356,856,363.05194,971,355.47
 归属于母公司股东的净利润(元) 578,884,934.79404,597,903.42198,731,128.32612,464,147.66489,073,265.39357,470,775.26194,629,337.80
盈利能力:
 销售毛利率(%) 26.1726.6027.4323.4124.6524.6426.61
 销售净利率(%) 13.1013.9814.8311.4012.0312.7013.83
 净资产收益率(%) 7.645.492.66----
 总资产报酬率ROA(%) 6.434.492.23----
 投入资本回报率ROIC(%) 6.014.322.096.865.624.152.24
营运能力:
 存货周转率(次) 2.471.560.66----
 应收账款周转率(次) 6.063.832.07----
 总资产周转率(次) 0.430.290.13----
偿债能力:
 资产负债率(%) 26.2124.8926.8428.2225.2825.6424.84
 股东权益比率(%) 73.7375.0573.1071.7374.7474.3775.16
 已获利息倍数(倍) -78.75-21.00-25.10-14.07-11.46-9.19-144.20
 流动比率 2.212.262.492.222.492.492.37
 速动比率 1.391.401.571.471.621.641.68
发展能力:
 营业收入增长率(%) 9.002.94-5.07-6.49-1.463.9319.90
 营业利润增长率(%) 19.5013.162.41-33.30-32.89-27.84-3.77
 税后利润增长率(%) 18.3613.182.11-33.49-32.17-27.79-2.88
 净资产增长率(%) 7.275.483.453.875.086.6612.27
 总资产增长率(%) 8.734.526.3614.5811.6414.0326.02

前瞻产业研究院